M
Maximilian Tischer
Researcher at University of Würzburg
Publications - 5
Citations - 327
Maximilian Tischer is an academic researcher from University of Würzburg. The author has contributed to research in topics: Gene & Ligand efficiency. The author has an hindex of 5, co-authored 5 publications receiving 286 citations.
Papers
More filters
Journal ArticleDOI
Quaternary Ammonium Salts and Their Antimicrobial Potential: Targets or Nonspecific Interactions?
TL;DR: A review of the structure–activity relationships and the modes of action of the various series of mono‐ and bisquaternary ammonium compounds found to have improved antimicrobial activity against mycobacteria and protozoa.
Journal ArticleDOI
Quaternary Ammonium Salts and Their Antimicrobial Potential: Targets or Nonspecific Interactions?
TL;DR: In this article, the structure-activity relationships and the modes of action of various series of (bis)quaternary ammonium compounds are discussed, and a review of their properties is presented.
Journal ArticleDOI
Mode-of-Action Studies of the Novel Bisquaternary Bisnaphthalimide MT02 against Staphylococcus aureus
T Menzel,Maximilian Tischer,Patrice Francois,Joachim Nickel,Jacques Schrenzel,Heike Bruhn,Annette E. Albrecht,Leane Lehmann,Ulrike Holzgrabe,Knut Ohlsen +9 more
TL;DR: The data presented suggest that the bisquaternary bisnaphthalimide MT02 exerts anti-Gram-positive activity by binding to DNA and thereby preventing appropriate DNA replication.
Journal ArticleDOI
The bisnaphthalimides as new active lead compounds against Plasmodium falciparum.
TL;DR: The qualitative analysis of the structure-activity relationships (SAR) revealed the importance of a long methylene middle chain of at least 8 methylene groups between the two bisquaternary naphthalimides or a monoquaternaryNaphthalIMide consisting of aLong alkyl chain attached to the positively charged nitrogen atom.
Journal ArticleDOI
Anti-trypanosomal activities and structural chemical properties of selected compound classes
Alicia Ponte-Sucre,Heike Bruhn,Tanja Schirmeister,Tanja Schirmeister,Alexander Cecil,Christian R. Albert,Christian Buechold,Maximilian Tischer,Susanne Schlesinger,Tim Goebel,Antje Fuß,Daniela Mathein,Benjamin Merget,Christoph A. Sotriffer,August Stich,Georg Krohne,Markus Engstler,Gerhard Bringmann,Ulrike Holzgrabe +18 more
TL;DR: Interestingly, the correlations found between the physico-chemical parameters of the selected compounds and those of commercial molecules that target specific organelles indicate that the rationale might be helpful to drive compound design toward high activities and acceptable pharmacokinetic properties for all compound families.